941 – 950 of 1279
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Associations of central and brachial blood pressure with cognitive function: a population-based study.
2015) In Journal of Human Hypertension(
- Contribution to journal › Article
-
Mark
Various outcomes of cholinesterase inhibitor treatment influence survival of patients with Alzheimer’s disease.
2015) 12th International Conference on Alzheimer`s and Parkinson`s Diseases (AD/PD 2015)(
- Contribution to conference › Poster
-
Mark
Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease : A prospective 9-year study
(
- Contribution to journal › Article
-
Mark
Large-scale assessment of polyglutamine repeat expansions in Parkinson disease
(
- Contribution to journal › Article
- 2014
-
Mark
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls
(
- Contribution to journal › Article
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.
(
- Contribution to journal › Article
-
Mark
Cerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.
(
- Contribution to journal › Article
-
Mark
Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro.
(
- Contribution to journal › Article
-
Mark
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
(
- Contribution to journal › Article